PitchSend

Investor Presentaiton

Investor Presentation First six months of 2018 Novo Nordisk has a strong leadership position within the growing diabetes care market Global diabetes care market by treatment class Global diabetes care value market share Slide 26 DKK billion 500 OAD GLP-1 Insulin Novo Nordisk Sanofi - Eli Lilly J&J - Novartis AstraZeneca Merck - Takeda Boehringer Ingelheim 30% 27% Total market: CAGR¹ 15.3% 400 Injectables: CAGR¹ 18.4% 25% 20% 300 CAGR¹ 34.4% 15% 200 CAGR¹ 16.4% 10% 100 5% CAGR¹ 11.6% 0 May 2008 0% May 2018 May 2008 May 2018 1 CAGR for 10-year period OAD: Oral Anti-diabetic Source: IQVIA MAT May, 2018 value figures changing diabetes® Source: IQVIA MAT May, 2018 value figures novo nordisk

View entire presentation